BioVeris Corporation

R&D agreement signed for diagnostics development

Published in Physician Business Week, February 1st, 2005

BioVeris Corporation (BIOV) and the Brooke Army Medical Center, Department of Clinical Investigation have entered into a Cooperative Research and Development Agreement (CRADA) to develop BioVeris Technology-based tests for the detection of clinical markers of disease and disease progression or recovery.

Work under the CRADA will occur over the next 2 years. BioVeris will be able to commercialize tests of clinical significance that may be identified. The CRADA is expected to provide research experience for the medical residents of the teaching program at Brooke Army Medical Center.

Diagnosis of disease is frequently based on the detection of specific...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Business Week

Source: Physician Business Week (2005-02-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry